Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 234

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Modeling shield immunity to reduce COVID-19 epidemic spread

Open access
Weitz, Joshua S., Beckett, Stephen J., Coenen, Ashley R., Demory, David, Dominguez-Mirazo, Marian, Dushoff, Jonathan, Leung, Chung-Yin, Li, Guanlin, Măgălie, Andreea, Park, Sang Woo, Rodriguez-Gonzalez, Rogelio, Shivam, Shashwat, Zhao, Conan Y. · 2020 · Nature Medicine

Abstract

The COVID-19 pandemic has precipitated a global crisis, with more than 1,430,000 confirmed cases and more than 85,000 confirmed deaths globally as of 9 April 20201–4. Mitigation and suppression of new infections have emerged as the two predominant public health control strategies5. Both strategies focus on reducing new infections by limiting human-to-human interactions, which could be both socially and economically unsustainable in the long term. We have developed and analyzed an epidemiological intervention model that leverages serological tests6,7 to identify and deploy recovered individuals8 as focal points for sustaining safer interactions via interaction substitution, developing what we term ‘shield immunity’ at the population scale. The objective of a shield immunity strategy is to help to sustain the interactions necessary for the functioning of essential goods and services9 while reducing the probability of transmission. Our shield immunity approach could substantively reduce the length and reduce the overall burden of the current outbreak, and can work synergistically with social distancing. The present model highlights the value of serological testing as part of intervention strategies, in addition to its well-recognized roles in estimating prevalence10,11 and in the potential development of plasma-based therapies12–15. A new study models the potential effects of preferentially deploying recovered individuals, who are seropositive for anti-SARS-CoV-2 antibodies, into the community to reduce the number of interactions between susceptible and infected people, thereby limiting transmission of the virus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-020-0895-3

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 234

Metadata

Authors
Weitz, J. S., Beckett, S. J., Coenen, A. R., Demory, D., Dominguez-Mirazo, M., Dushoff, J., Leung, C.-Y., Li, G., Măgălie, A., Park, S. W., Rodriguez-Gonzalez, R., Shivam, S., & Zhao, C. Y.
Venue
Nature Medicine
Published
2020-05-07
Volume
26
Issue
6
Pages
849-854
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3021186497
Cited by
234
References
10
FWCI
8.38
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling shield immunity to reduce COVID-19 epidemic spread. https://app.cochat.ai/papers/10.1038/s41591-020-0895-3
The paper
Weitz, J. S., Beckett, S. J., Coenen, A. R., Demory, D., Dominguez-Mirazo, M., Dushoff, J., Leung, C.-Y., Li, G., Măgălie, A., Park, S. W., Rodriguez-Gonzalez, R., Shivam, S., & Zhao, C. Y. (2020). Modeling shield immunity to reduce COVID-19 epidemic spread. Nature Medicine. https://doi.org/10.1038/s41591-020-0895-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.